Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Chandrani Mukherjee is active.

Publication


Featured researches published by Chandrani Mukherjee.


Bioorganic & Medicinal Chemistry Letters | 2010

Derivatives of aryl amines containing the cytotoxic 1,4-dioxo-2-butenyl pharmacophore.

Amitabh Jha; Chandrani Mukherjee; Ashok K. Prasad; Virinder S. Parmar; Manjula Vadaparti; Umashankar Das; Erik De Clercq; Jan Balzarini; James P. Stables; Anuraag Shrivastav; Jonathan R. Dimmock

Several series of compounds containing the 1,4-dioxo-2-butenyl moiety have been prepared as candidate cytotoxins, including the methyl N-arylmaleamates, methyl N-arylfumaramates, and N-arylmaleimides. In addition, the N-arylisomaleimides were synthesized which are the structural isomers of N-arylmaleimides. These compounds were evaluated against human Molt 4/C8 and CEM T-lymphocytes as well as murine L1210 cells. Methyl N-arylfumaramates showed the highest cytotoxic potencies and, in particular, methyl N-(3,4-dichlorophenyl)fumaramate is six times more potent than melphalan towards L1210 cells and is equipotent with this drug in the Molt 4/C8 assay. Electrophilicity of compounds under investigation was demonstrated by carrying out thiolation using model benzyl mercaptan on representative compounds. Methyl N-(3,4-dichlorophenyl)fumaramate and methyl N-(4-chlorophenyl)maleamate inhibited human N-myristoyltransferase, a possible molecular target, in high micromolar range. QSAR and molecular modeling revealed some correlations between different structural features of a number of the molecules and cytotoxic potencies. Methyl N-arylfumaramates were well tolerated in mice in comparison to the analogs in other series of compounds tested. The data obtained in this investigation affords guidelines for preparing new series of molecules with greater potencies.


Pure and Applied Chemistry | 2005

Selective transacylation reactions on 4-aryl-3,4-dihydropyrimidin-2-ones and nucleosides mediated by novel lipases*

Poonam; Ashok K. Prasad; Chandrani Mukherjee; Gaurav Shakya; Gautam K. Meghwanshi; Jesper Wengel; Rajendra Kumar Saxena; Virinder S. Parmar

Different (±)-4-(3/4-acetoxyaryl)-5-ethoxycarbonyl-6-methyl-3,4-dihydropyrimidin-2-ones have been synthesized and subjected to enantioselective deacetylation reactions mediated by different lipases in organic media. Novozyme 435 in tetrahydrofuran:diisopropyl ether was found to be the catalyst of choice for efficient enantioselective deacetylation of dihydropyrimidinones under study. Further, we discovered that lipase isolated from Pseudomonas aeruginosa can be used for selective acylation of secondary hydroxyl groups in nucleosides. This observation can be very useful for selective manipulation of different hydroxyl groups in nucleosides.


Biochemistry | 2005

Novel aromatic ester from Piper longum and its analogues inhibit expression of cell adhesion molecules on endothelial cells.

Sarvesh Kumar; Pragya Arya; Chandrani Mukherjee; Brajendra K. Singh; Naresh Singh; Virinder S. Parmar; Ashok K. Prasad; Balaram Ghosh


Bioorganic & Medicinal Chemistry | 2006

Microwave-assisted synthesis of antimicrobial dihydropyridines and tetrahydropyrimidin-2-ones: Novel compounds against aspergillosis☆

Anil Kumar Chhillar; Pragya Arya; Chandrani Mukherjee; Pankaj Kumar; Yogesh Yadav; Ajendra K. Sharma; Vibha Yadav; Jyotsana Gupta; Rajesh Dabur; Hirday N. Jha; Arthur C. Watterson; Virinder S. Parmar; Ashok K. Prasad; Gainda L. Sharma


Bioorganic & Medicinal Chemistry | 2007

E,E,E-1-(4-Arylamino-4-oxo-2-butenoyl)-3,5-bis(arylidene)-4-piperidones: A topographical study of some novel potent cytotoxins

Amitabh Jha; Chandrani Mukherjee; Ashok K. Prasad; Virinder S. Parmar; Erik De Clercq; Jan Balzarini; James P. Stables; Elias K. Manavathu; Anuraag Shrivastav; Kurt H. Nienaber; Gordon A. Zello; Jonathan R. Dimmock


Bioorganic & Medicinal Chemistry Letters | 2007

Cytostatic activity of novel 4'-aminochalcone-based imides.

Amitabh Jha; Chandrani Mukherjee; Alfred J. Rolle; Erik De Clercq; Jan Balzarini; James P. Stables


Journal of Molecular Catalysis B-enzymatic | 2010

Enzyme-assisted kinetic resolution of novel 2-naphthol Mannich bases

Chandrani Mukherjee; Erin D. MacLean; T. Stanley Cameron; Amitabh Jha


Synlett | 2007

A Convenient One-Pot Synthesis of 2,2-Dialkyl-2,3-dihydro-1H-naphtho[2,1-b]pyrans

Amitabh Jha; Po-Jung Jimmy Huang; Chandrani Mukherjee; Nawal K. Paul


Journal of Molecular Catalysis B-enzymatic | 2006

Synthesis and lipase-catalyzed resolution studies on novel (±)-2-(2-acetoxyethyl)-4-arylmethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-carboxylates

Ashok K. Prasad; Chandrani Mukherjee; Deepti Sharma; Soumya Rastogi; Anshuman Mangalam; Amitabh Jha; Carl Erik Olsen; Shamkant Anant Patkar; Virinder S. Parmar


Journal of Molecular Catalysis B-enzymatic | 2006

Novel selective biocatalytic deacetylation studies on dihydropyrimidinones

Ashok K. Prasad; Chandrani Mukherjee; Sunil K. Singh; Raju Brahma; R. K. Singh; Rajendra Kumar Saxena; Carl Erik Olsen; Virinder S. Parmar

Collaboration


Dive into the Chandrani Mukherjee's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Erik De Clercq

Rega Institute for Medical Research

View shared research outputs
Top Co-Authors

Avatar

Jan Balzarini

Rega Institute for Medical Research

View shared research outputs
Top Co-Authors

Avatar

James P. Stables

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge